Appointments: Prana, Octapharma, ABPI, Gamida and Allergy Therapeutics

This week's roundup includes senior appointments by Prana Biotechnology, Octapharma, Silence Therapeutics and ABPI, in addition to board appointments by Gamida Cell and Allergy Therapeutics.

Prana Biotechnology Ltd. has named David Stamlerchief medical officer and senior vice president, clinical development. Stamler was previously vice president, clinical development and therapeutic head, movement disorders at Teva Pharmaceutical Industries Ltd.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Executives On The Move

More from Leadership